Annual Cell & Gene Therapy Innovation Leaders Summit
7 – 8 February 2018 at Crowne Plaza Potsdamer Platz, Berlin, Germany
The Annual Cell and Gene Therapy Innovation Summit is the only executive gathering committed to creating an advanced networking platform to increase innovation and collaboration within the Cell & Gene Therapy area.
Our cutting-edge programme covers key subjects such as ATMP development, scale-up, and scale-out, manufacturing data, R&D, CART therapies, global regulatory affairs, stem cells, cord blood, pricing & reimbursement, pre-clinical & clinical, improving cost efficiency, commercialization, as well as closed system processing, and GMP compliance. Bringing on board global leaders of the industry, this summit is not to be missed!
Confirmed Speakers include:
Magda Papadaki – Head of Product and Process Innovation – ABPI
Stefan Glueck – Vice President, Global Medical Affairs – Celgene
Shirley Bartido – Director of Regulatory Affairs – Cellectis
Yen Choo – Executive Chairman – Plasticell
Sandra van Wetering – Chief Operations Officer – DCPrime
Christine Le Bec – Head of Analytical Development – Genethon
Ajan Reginald – CEO – Celixir
Anthony Lodge – Biopharm Regulatory, CMC Manager – GlaxoSmithKline
and many more!
The latest speaker addition is Dragan Primorac, former Minister of Science, Education and Sports (2003-2009) for the Republic of Croatia, and currently Professor and Penn State University Global Ambassador with St. Catherine Hospital. Dr. Primorac will be speaking on “The Future of Cartilage Repair”.
This content is blocked. Accept cookies to view the content.